Every agent in the ophthalmology lecture, with indication, patient education, side effects, contraindications and mechanism. 30 entries, each citing its slide. Indication, education, side effects and contraindications come FIRST, because mechanism is the part already over-weighted.
In the recording, on the topical vasoconstrictors: “Most of you will probably forget this and we’ll get it wrong on the test. But I will tell you, I will ask this question … there’s rebound hyperemia … star that, underline it, highlight it. A lot of people still get it wrong every test. I don’t know why because I tell you explicitly, that’s what I’m going to be asking about.”
So: no more than two weeks, because prolonged use causes rebound hyperemia on stopping; and if no improvement in 72 hours, stop and see a provider. He noted the same trap returns with nasal sprays in ENT.
| Agent | Indication | Patient education | Side effects | Contraindications & cautions | Mechanism | Slide |
|---|---|---|---|---|---|---|
| Erythromycin (ointment) | Superficial conjunctival or corneal infection; prophylaxis of ophthalmia neonatorum | Soothing on an inflamed eye, so it may be used even when bacterial infection is not confirmed. Dirt cheap. | Ocular irritation, hypersensitivity — shared by essentially every ophthalmic antibiotic | None specific | Blocks transpeptidation at the 50S ribosome | slide 15 |
| Azithromycin (AzaSite) | Bacterial conjunctivitis | Given twice daily rather than four or more times — but considerably more expensive, so not used as often clinically. | Ocular irritation, hypersensitivity | Cost is the practical barrier | Blocks transpeptidation at the 50S ribosome | slide 17 |
| Ciprofloxacin (Ciloxan) | Conjunctivitis, keratitis, corneal ulcers, blepharitis, dacryocystitis | A WHITE PRECIPITATE appears in about 17% — specific to this agent, and worth warning about so it is not mistaken for worsening. | Ocular irritation, white precipitate, unpleasant taste after instillation | Emerging resistance; expensive | Inhibits DNA gyrase and topoisomerase IV | slide 21 |
| Moxifloxacin (Vigamox), ofloxacin, levofloxacin, gatifloxacin | Conjunctivitis; corneal ulcers | PREFERRED for corneal ulcers or suspected Pseudomonas, and for conjunctivitis in CONTACT LENS WEARERS once keratitis is excluded. | Ocular irritation, unpleasant taste after instillation | Expensive; emerging resistance | Inhibits DNA gyrase and topoisomerase IV | slide 22 |
| Gentamicin, tobramycin (Tobrex) | Conjunctivitis and external infections of the eye and adnexa | Watch for CORNEAL ULCERATION and reactive keratoconjunctivitis after several days of use — the one adverse effect specific enough to attach to a class. | Ocular irritation, CORNEAL ULCERATION, reactive keratoconjunctivitis | Prolonged use | Binds the 30S ribosomal subunit | slide 23 |
| Sulfacetamide sodium | Bacterial conjunctivitis and other superficial ocular infection | Ask about sulfa allergy before prescribing. | Ocular irritation, allergic reactions | AVOID in sulfonamide allergy | Antagonizes PABA to block folic acid synthesis | slide 19 |
| Bacitracin (ointment) | Bacterial conjunctivitis, blepharitis, keratitis, corneal ulcers, meibomianitis | Inexpensive ointment for lid and surface disease. | Ocular irritation | None specific | Blocks cell wall synthesis by preventing mucopeptide transfer | slide 20 |
| Trimethoprim / polymyxin B (Polytrim) | Bacterial conjunctivitis | A combination of two different mechanisms in one drop. | Ocular irritation | None clinically | Trimethoprim blocks reduction of folic acid to tetrahydrofolate; polymyxin B binds membrane phospholipids and lets contents leak | slide 18 |
| Agent | Indication | Patient education | Side effects | Contraindications & cautions | Mechanism | Slide |
|---|---|---|---|---|---|---|
| Natamycin (Natacyn) | Conjunctivitis and keratitis from Aspergillus, Candida, Cephalosporium, Fusarium, Penicillium | THE ONLY commercially available ophthalmic antifungal. Everything else is compounded or systemic. Risk factors for ocular fungal infection: trauma, chronic ocular surface disease, contact lens wear, immunosuppression INCLUDING topical steroid use. | Ocular irritation | None specific | Binds sterol, increasing fungal cell membrane permeability | slide 32 |
| Agent | Indication | Patient education | Side effects | Contraindications & cautions | Mechanism | Slide |
|---|---|---|---|---|---|---|
| Ketotifen (Zaditor, OTC), olopatadine, azelastine, alcaftadine, bepotastine, emedastine, epinastine | Ocular allergy | Onset within MINUTES; allow two weeks to judge full efficacy. Typically PREFERRED over mast cell stabilizers. | Ocular irritation, headache, INCREASED ocular dryness | No significant interactions | H1 INVERSE AGONISTS — they inactivate the receptor rather than simply blocking it, and remain competitive with histamine | slide 42 |
| Cromolyn (Opticrom), lodoxamide (Alomide), nedocromil (Alocril) | Predictable seasonal allergy in patients who cannot tolerate other therapy | 5 to 14 days for full efficacy and NOT useful for acute symptoms. Often four times daily, which is not ideal. | Ocular irritation, unpleasant taste, headache | None specific | Inhibit mast cell degranulation, limiting histamine, tryptase and prostaglandin D2 | slide 45 |
| Tetrahydrozoline (Opti-Clear), naphazoline (VasoClear), naphazoline with pheniramine (Visine-A) | Short-term relief of conjunctival redness and edema | ★ NO MORE THAN TWO WEEKS — prolonged use causes REBOUND HYPEREMIA on stopping. If no improvement within 72 HOURS, stop and see a provider. The same trap appears with nasal sprays. | REBOUND HYPEREMIA after discontinuation | Prolonged use; accidental ingestion in children | Alpha-1 agonist LOCALLY; these imidazolines target alpha-2 SYSTEMICALLY, which is what makes an ingestion dangerous | slide 48 |
| Agent | Indication | Patient education | Side effects | Contraindications & cautions | Mechanism | Slide |
|---|---|---|---|---|---|---|
| Bromfenac, diclofenac, flurbiprofen, ketorolac, nepafenac | Postoperative inflammation and pain; allergic conjunctivitis | NOT routinely recommended for conjunctivitis. | Lacrimation, keratitis, RAISED intraocular pressure, ocular irritation | Caution where pressure matters | Block cyclooxygenase, stopping conversion of arachidonic acid to prostaglandins and thromboxanes | slide 51 |
| Dexamethasone, prednisolone (Pred Forte), difluprednate | Severe ocular allergy, anterior uveitis, external eye inflammatory disease, inflammation after ocular surgery | Limited to a pulse of LESS THAN TWO WEEKS. Generally reserved for refractory symptoms. | CATARACT formation, raised pressure and glaucoma, infection from reduced immune function, delayed wound healing, corneal ulcers | Raised pressure is MORE LIKELY WITH A FAMILY HISTORY | Inhibit phospholipase A2, cutting off arachidonic acid derived mediators; also inhibit fibrin and collagen deposition, reducing scarring | slide 52 |
| Fluorometholone (FML), loteprednol (Alrex), rimexolone (Vexol) | As for the other ocular steroids | The SOFT STEROIDS — lower risk of raising intraocular pressure. | Same class risks, but less pressure elevation | Same cautions, reduced | As for the glucocorticoids | slide 55 |
| Agent | Indication | Patient education | Side effects | Contraindications & cautions | Mechanism | Slide |
|---|---|---|---|---|---|---|
| Cyclosporine (Restasis) | Chronic dry eye with inflammation — keratoconjunctivitis sicca | Treat the underlying disease first. Systemic causes: Sjogren syndrome, rheumatoid arthritis, vitamin A deficiency, Stevens-Johnson syndrome. | OCULAR BURNING (17%), foreign body sensation, blurred vision | None specific | Inhibits production and release of interleukin 2, reducing T cell activation; raises tear production | slide 58 |
| Agent | Indication | Patient education | Side effects | Contraindications & cautions | Mechanism | Slide |
|---|---|---|---|---|---|---|
| Latanoprost (Xalatan), travoprost, bimatoprost (Lumigan), tafluprost | Open-angle glaucoma — FIRST LINE and the most commonly used | ONCE DAILY and do not exceed it — more frequent dosing INHIBITS the pressure-lowering effect. Warn about lash and iris changes. | Conjunctival hyperemia, ocular irritation, CHANGES IN EYELASH LENGTH AND IRIS COLOR | Limited systemic side effects | Prostaglandin F2 alpha analogs; increase aqueous OUTFLOW | slide 65 |
| Timolol (Timoptic), carteolol, levobunolol — nonselective | Open-angle glaucoma — second line | Nonselective is MORE efficacious in the eye because beta-2 receptors predominate there — but that is also why it is worse tolerated. | Worsening heart failure, BRADYCARDIA, heart block, INCREASED AIRWAY RESISTANCE | Asthma, heart failure, bradyarrhythmia | Block beta receptors in ciliary body epithelium; less cyclic AMP, less aqueous PRODUCTION | slide 67 |
| Betaxolol (Betoptic-S) — beta-1 selective | Open-angle glaucoma | The selective option, so LESS risk of bronchoconstriction in a patient with asthma. | As for the class, reduced respiratory risk | Still cardiac caution | Selective beta-1 blockade; reduces aqueous production | slide 68 |
| Brimonidine (Alphagan P), apraclonidine (Iopidine) | Open-angle glaucoma — the only class doing BOTH jobs | Brimonidine is more lipophilic; apraclonidine is highly ionized at physiological pH. Allergic conjunctivitis is LESS common with brimonidine. | Ocular irritation, hyperemia (rebound effect), pruritus, allergic conjunctivitis | CONTRAINDICATED IN CHILDREN UNDER TWO — central nervous system depression and apnea | Alpha-2 agonists; decrease production AND increase outflow | slide 69 |
| Dorzolamide (Trusopt), brinzolamide (Azopt) | Open-angle glaucoma | Warn about the taste and the sting — both are common enough to cause people to stop. | BITTER TASTE (25%), burning or stinging (33%), allergic conjunctivitis | Sulfonamide-derived | Inhibit carbonic anhydrase in ciliary body epithelium; less bicarbonate, less fluid transport | slide 70 |
| Pilocarpine (Pilopine HS), carbachol (Miostat), acetylcholine (Miochol-E) | Open-angle glaucoma; acetylcholine in surgical settings | Poor compliance from side effects and frequent dosing. YOUNGER patients are usually intolerant because of the visual blurring. | FIXED SMALL PUPILS, myopia, visual disturbance, headache | Younger patients tolerate miotics poorly | Activate muscarinic receptors; ciliary muscle contraction facilitates OUTFLOW | slide 72 |
| Agent | Indication | Patient education | Side effects | Contraindications & cautions | Mechanism | Slide |
|---|---|---|---|---|---|---|
| Proparacaine (Alcaine), tetracaine (Altacaine) | Tonometry, foreign body removal, superficial corneal surgery | ★ DO NOT WRITE PRESCRIPTIONS FOR THESE. The eye stays numb 10 to 20 minutes with NO BLINK REFLEX. | Hypersensitivity, burning sensation | Never dispensed for home use | Inhibit sodium influx into the neuron, preventing signal propagation | slide 75 |
| Tropicamide (Mydriacyl), cyclopentolate (Cyclogyl), atropine | Fundoscopic examination; uveitis, to prevent synechiae and relieve ciliary spasm | Mydriasis. The pupil is LESS reactive to light than with a sympathomimetic. | Photosensitivity, blurred vision | Caution where dilation is unsafe | Antimuscarinics — competitively block muscarinic acetylcholine receptors | slide 76 |
| Phenylephrine (Neo-Synephrine) | Mydriasis for examination | The dilated pupil stays MORE REACTIVE TO LIGHT than with an antimuscarinic. | Photosensitivity, conjunctival hyperemia | Caution in cardiovascular disease | Adrenergic receptor agonist | slide 77 |
| Fluorescein | Anterior segment staining; disclosing corneal injury | Reveals epithelial defects of the cornea and conjunctiva. | Hypersensitivity, burning sensation | None specific | Stains epithelial defects | slide 78 |